NVision, a startup specializing in cancer imaging, has secured $38 million in funding led by Abbott, with an additional $17 million venture loan. The company utilizes quantum technology to enhance MRI scans, allowing for real-time monitoring of a tumor's metabolic response to treatment. This innovation aims to provide faster feedback on therapy effectiveness, potentially changing treatment timelines from months to days. NVision plans to expand its metabolic imaging system to 20 centers globally and is preparing for human clinical studies in 2027. AI
影响 This technology leverages advanced imaging and quantum principles, potentially impacting drug discovery and personalized medicine.
排序理由 Significant funding round for an innovative health tech company. [lever_c_demoted from significant: ic=1 ai=0.4]
- Abbott
- European Investment Bank
- Memorial Sloan Kettering Cancer Center
- NVision
- Playground Global
- MD Anderson
- UCSF
- University of Cambridge
AI 生成摘要 · Google Gemini · 来自 1 个来源。 我们如何撰写摘要 →
